Jody Leise, APRN, CNS in Lake City, MN - Clinical Nurse Specialist

Jody Leise, APRN, CNS is a Clinical Nurse Specialist - Adult Health based in Lake City, Minnesota. Jody Leise is licensed to practice in Minnesota (license number 24) and her current practice location is 500 W Grant St, Lake City, Minnesota. She can be reached at her office (for appointments etc.) via phone at (651) 345-6711.

NPI number for Jody Leise is 1346951233 and her current mailing address is 2770 Southview Rdg, Red Wing, Minnesota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1346951233.

Contact Information

	Jody Leise, APRN, CNS
	500 W Grant St, Lake City, MN 55041-1143
	(651) 345-6711
	Not Available

Provider's Profile

Full Name	Jody Leise
Gender	Female
Speciality	Clinical Nurse Specialist - Adult Health
Location	500 W Grant St, Lake City, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1346951233
Provider Enumeration Date: 12/12/2022
Last Update Date: 12/12/2022

Medical Identifiers

Medical identifiers for Jody Leise such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346951233	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364SA2200X	Clinical Nurse Specialist - Adult Health	24 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jody Leise is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jody Leise, APRN, CNS 2770 Southview Rdg, Red Wing, MN 55066-7160 Ph: () -	Jody Leise, APRN, CNS 500 W Grant St, Lake City, MN 55041-1143 Ph: (651) 345-6711

News Archive

Results from Boehringer Ingelheim's afatinib Phase III lung cancer trial

Highly anticipated results from LUX-Lung 3, the pivotal Phase III lung cancer trial investigating Boehringer Ingelheim's front running oncology investigational compound, the ErbB Family Blocker afatinib, in patients with EGFR mutations, will be presented at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from 1 - 5 June 2012.

Gene therapies correct three forms of retinal degenerative diseases

Gene therapies developed by University of Pennsylvania School of Veterinary Medicine researchers have worked to correct different forms of blindness. While effective, the downside to these approaches to vision rescue is that each disease requires its own form of gene therapy to correct the particular genetic mutation involved, a time consuming and complex process.

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Researchers shows a fully human immunoglobulin (IgG) that potently inhibits SARS-CoV-2 infection.

Study analyzes nursing unit layout for improved spatial flow

In hospitals, poor floor design, storage closet clutter and crowded corridors can contribute to nurse and medical staff fatigue. These distractions can hurt patient care quality and result in higher medical costs. Now, a new Cornell University study offers a spatial solution.

Clinton foundation releases donor list

Former president Bill Clinton on Friday released a list of the donors who have given money to his foundation "under an agreement with President Obama to prevent the appearance of conflicts with Hillary Rodham Clinton's role as secretary of state," the Washington Post reports.

Jody Leise, APRN, CNS - Clinical Nurse Specialist in Lake City, MN